DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.compose your message
message sent
email sent successfully
Trusted Resources: News & Events
Latest announcements and gatherings
Community Congress Ad Hoc COVID-19 Response Working Group Webinar
Community Congress Ad Hoc COVID-19 Response Working Group Webinar
Tuesday April 7 at 4:00pm EST
This webinar will be hosted by teleconference ONLY, not in-person.
Use Webex Link to view slides
or dial 1-650-479-3208
Access Code 665 002 154
Password (if prompted) 1234
This event has ended.


Related Content
-
education & researchFDA advises patients on use of non-steroidal anti-inflammatory drugs (NSAIDS) for COVID-19[3/19/2020] FDA is aware of news reports...
-
news & eventsDepression & the Sickle Cell Warrior – WebinarThe Sickle Cell Mental Health Initiative...
-
news & eventsExpert Opinion Hydroxyurea Could Prevent Strokes for People With Sickle Cell Disease in Lieu of Transfusions During ...The COVID-19 pandemic threatens to cause...
-
videos & visualsYou Should Get a COVID-19 Vaccine – Frenchhttps://www.youtube.com/watch?v=5DMfiyA0...
-
news & eventsRDLA April 2020 Legislative Webinar – Rare Disease Legislative AdvocatesRare Disease Legislative Advocates Powe...
-
education & researchCOVID-19: Highest Risk Patients are Asked to Stay at Home for 12 Weeks [England]A million and a half people in England w...
-
news & eventsIn Support of Rare Disease Patients Impacted by COVID-19, NORD Launches Premium and Limited Medical Relief ProgramUnited with more than 25 million America...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Support for this site is provided by

This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.